NCT03409419 - PET Imaging of the Immune System Using Analog Probes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 10, 2018

Primary Completion Date

November 10, 2020

Study Completion Date

November 10, 2020

Conditions

Malignant Melanoma

Interventions

DRUG

[18F] CFA

pilot study to evaluate the bio-distribution of \[18F\] CFA, a new tracer for imaging the purine nucleoside biosynthetic pathway, before and after immunotherapy treatment in patients with metastatic or recurrent advanced melanoma.

Trial Locations (1)

90095

University of California, Los Angeles, Los Angeles